Moderna headquarters in Cambridge, Massachusetts.Moderna’s first-quarter revenue was slashed nearly in half over the course ...
The drugmaker is optimistic about higher sales with new vaccines and a little help from AI in the coming years.
Pfizer, Inc. on Wednesday forecast 2024 sales that could be as much as $5 billion below Wall Street expectations, driving shares down 9% to a 10-year low. Moderna says its updated coronavirus ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window WASHINGTON -- The benefits of combination vaccines may seem ...
, opens new tab said on Thursday it had paused its plans to build a vaccine manufacturing facility in Kenya, following a post-pandemic decline in demand for COVID-19 vaccines. The move is in line ...
Among their more prominent programs, Moderna is developing a vaccine-based treatment for solid tumors. Moderna's personalized neoantigen vaccine, mRNA-4157, has shown promising results in clinical ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. US biotech Moderna has put plans to build a vaccine plant in Kenya on hold, in a sign that moves to invest ...
A new study from the CDC states that there is no data to support an association between the COVID vaccines and sudden cardiac death among previously healthy young persons The COVID-19 vaccines are ...
Kenya's tourism minister, clarified that while the agreement is not entirely terminated, it has been put on hold for evaluation. Moderna has stalled on purchasing land in the Tatu City economic ...
One of the world’s top vaccine-makers is partnering with a major AI company to advance medicine — and its chief executive is excited. Moderna and OpenAI announced an ongoing partnership ...